Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NKTR-118 in Opioid-Induced Constipation
NCT00600119Phase 2Completed
- Sponsor
- AstraZeneca
- Start
- Dec 2007
- Primary completion
- Mar 2009
- Modality
- Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 2 trial of naloxegol in opioid-induced constipation (OIC), sponsored by AstraZeneca. Started Dec 2007; status: completed.
02
Drugs
naloxegol
03
Conditions
opioid-induced constipation (OIC)
Beyond the preview
Go deeper on NCT00600119.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00600119.